Electromyography (EMG) is a diagnostic and monitoring technique that records the electrical activity generated by skeletal muscle fibers, typically through surface or needle electrodes. In medical devices, EMG systems detect, amplify, and interpret these bioelectric signals to assess neuromuscular function, drive prosthetic control, or support rehabilitation and intraoperative monitoring.
What is Electromyography (EMG)?
EMG measures the electrical potentials generated when motor neurons activate muscle fibers. The motor unit action potential, the basic signal EMG captures, travels through tissue and is picked up by electrodes on the skin (surface EMG) or inserted into muscle (needle or fine-wire EMG). The raw signal is amplified, filtered, and digitized before it becomes usable data.
In a medical device context, EMG shows up in two ways: as a standalone diagnostic modality used by neurologists, and as a sensing layer embedded inside other products. Prosthetic hands read surface EMG to decide when to open or close a grip. Rehabilitation devices use EMG as biofeedback, and critical care monitors use it to track neuromuscular blockade during surgery.
Why Electromyography (EMG) matters in medical device development
Getting EMG signal acquisition wrong has direct clinical consequences. Noise, motion artifact, or poor electrode contact can produce a signal that looks clean but doesn’t reflect real muscle activity, dangerous in a device used to diagnose neuromuscular disease or to gate a prosthetic’s grip force. In surgical neuromonitoring, a missed or delayed EMG response can mean a nerve injury goes undetected until after the procedure.
Regulators treat EMG equipment as a defined device category with its own particular safety standard, not a generic sensor. The design history file needs to show that the signal chain, from electrode to display, was verified against real physiological ranges and validated for its intended use. Skipping that work shows up during FDA review or a notified body audit as a delay rather than a quick fix.
How Electromyography (EMG) works
An EMG system is built around a signal chain that has to preserve a small, noisy biological signal.
- Electrodes. Surface electrodes (Ag/AgCl) sit on the skin over a target muscle; needle or fine-wire electrodes are inserted for higher spatial resolution and access to deep muscles.
- Amplification and filtering. Raw EMG amplitude falls in the microvolt to low-millivolt range, so the front end needs high common-mode rejection to separate muscle signal from noise and adjacent activity like ECG.
- Analog-to-digital conversion. The filtered signal is digitized at a sampling rate high enough to capture the relevant frequency content, generally into the low kilohertz range for surface EMG.
- Signal processing. Software extracts features such as amplitude, frequency content, or onset timing, depending on whether the goal is diagnosis, device control, or biofeedback.
- Output. Results appear as a waveform, a numeric score, or a control input, for example, driving a prosthetic actuator or triggering an alarm.
IEC 60601-2-40 is the particular standard for electromyographs and evoked response equipment, applied on top of IEC 60601-1. In the US, a diagnostic electromyograph is a Class II device under 21 CFR 890.1375, subject to premarket notification. Risk management follows ISO 14971, and software for signal processing or control logic falls under IEC 62304. In the EU, EMG devices are assessed under EU MDR 2017/745, typically as active diagnostic devices under Annex VIII.
Common challenges and best practices
Electrode placement is the most common source of bad data. A surface electrode a few millimeters off target, or over the wrong muscle belly, produces a signal that looks plausible but measures the wrong thing. Teams that treat placement as a packaging afterthought, rather than testing across real anatomical variation, tend to find this problem late.
Motion artifact and cross-talk from nearby muscles are the next most common failure mode, especially in wearable or ambulatory EMG devices where the electrode isn’t fixed in a clinical setting. Good designs address this with electrode geometry, adhesive selection, and filtering, validated against movement conditions that match actual use, not bench testing on a seated subject.
Teams also underestimate how much clinical and usability evidence an EMG-based control input needs, especially when the output drives an actuator. Usability engineering under IEC 62366-1 has to account for how a clinician or patient actually places electrodes. And because EMG systems combine hardware, signal processing, and often software, a change to any one layer can trigger revalidation across the whole chain without proper change control in place.
How SJML helps with Electromyography (EMG)
SJML designs and manufactures electromechanical medical devices that depend on clean bioelectric signal acquisition, from the analog front end through embedded software and enclosure design. For products built around EMG or related neuromuscular sensing, in patient monitoring, rehabilitation, or electrotherapy platforms, SJML’s design and engineering teams handle circuit design, embedded firmware, and risk management under ISO 14971, backed by in-house IEC 60601 and EMC testing labs. QARA support covers device classification, regulatory submissions, and post-market surveillance once the product ships.
Talk to SJML’s engineering team →
Frequently asked questions
No. EMG measures electrical activity in skeletal muscle, while ECG (electrocardiography) measures the heart’s electrical activity. Both are bioelectric signals collected through electrodes, but they target different tissues and require different signal conditioning and filtering. In some applications, muscle activity can introduce artifacts into ECG recordings, so systems often include algorithms or hardware to distinguish between the two.
Surface EMG (sEMG) uses electrodes placed on the skin and is non-invasive, making it suitable for rehabilitation, sports science, prosthetic control, and wearable medical devices. Needle EMG uses fine electrodes inserted directly into muscle tissue, providing higher spatial resolution and access to deep muscles. It is primarily used for clinical diagnosis of neuromuscular disorders rather than long-term monitoring.
IEC 60601-2-40 is the particular standard covering the basic safety and essential performance of electromyographs and evoked response equipment, used together with IEC 60601-1. In the United States, diagnostic electromyographs are regulated under 21 CFR 890.1375 as Class II medical devices, typically requiring 510(k) clearance before marketing.
Yes. Myoelectric prosthetic systems use surface EMG electrodes placed over residual muscles to detect muscle activation patterns. Embedded algorithms convert these signals into commands that control gripping, wrist rotation, or other powered movements. Reliable performance depends on consistent electrode placement, robust signal processing, and validation across real-world conditions such as sweat, movement, and varying skin impedance.
Intraoperative neuromonitoring (IONM) uses EMG to monitor nerve function continuously during procedures involving structures such as the spinal cord, cranial nerves, or peripheral nerves. Real-time EMG activity alerts the surgical team when a nerve is stretched, compressed, or otherwise at risk, allowing corrective action before permanent injury occurs. This approach is widely used in spine surgery, thyroid surgery, ENT procedures, and neurosurgery.
Related terms
- Surface Electromyography (sEMG)
- Intraoperative Neuromonitoring (IONM)
- Myoelectric Control
- IEC 60601-2-40
- Design Verification
